BOFAS Abstracts Archive

You can search for abstracts by using the search bar below.
Alternatively you can browse through podium and poster presentations by selecting the year and / or type below. You can further refine your search using tags or use the search bar.

 



Categories: Abstracts, 2023, Poster

Outcomes following extracorporeal shockwave therapy for the treatment of insertional and non-insertional Achilles tendinopathy at 2 year follow-up: a retrospective review

J. Butler, D. Zheng, B. DeClouette, C. Walls, G. Jejelava, M. Azam, J. Kennedy

1NYU Langone Health, Orthopaedics, New York, United States

2John Peter Smith, Fort Worth, United States

Introduction: The purpose of this retrospective clinical study was to evaluate outcomes following extracorporeal shockwave therapy (ESWT) for the treatment of Achilles tendinopathy.

Methods: This retrospective cohort study included clinical data from 95 patients who underwent ESWT for insertional (IAT) or non-insertional (NAT) Achilles tendinopathy between 3/3/2017 to 2/8/2022 with a minimum of 1 year follow-up. Data regarding patient demographics, subjective clinical outcomes, radiographic outcomes, treatment characteristics, complications and failures were recorded. Failure was defined as no improvement in VISA-A nor VAS scores and/ or surgical intervention. Subgroup analysis was conducted to identify predictors of poor outcomes. Paired student’s t-tests and Welch’s t-tests were calculated. Regression analysis was carried out to identify predictors of poor outcomes.

Results: In total, 95 patients (109 ankles) with a mean age of 54.1 ± 14.0 years underwent ESWT for Achilles tendinopathy at a mean follow-up of 25.7 ± 15.0 months. Thirty-nine patients were in the NAT cohort and 56 patients were in the IAT cohort. Both NAT and IAT cohorts had a similar improvement in VISA-A score (p=0.365), VAS scores (p=0.65) and demonstrated a similar return to play time (p=0.34). There was a higher failure rate in the IAT cohort (51.8%) than the NAT cohort (23.1%). Patients who received platelet-rich plasma (PRP) had a higher failure rate (71.4%) than those who did not receive PRP (19.6%). Regression models found that treatment with PRP, MRI severity and female sex were associated with worse outcomes.

Conclusion: This retrospective study demonstrated a high failure rate at short-term follow-up in patients who underwent ESWT for insertional Achilles tendinopathy. Predictors of poor outcomes included treatment with PRP, MRI severity and female sex. Further studies with larger patient cohorts and longer follow-up are necessary to determine the role of ESWT in the treatment of Achilles tendinopathy.

Previous Article Outcomes and complications of 76 operatively treated pilon fractures of the distal tibia
Next Article Outcomes following surgical excision of interdigital Morton's neuroma: a prospective study
Print


Click thumbnail below to view poster / thumbnail:

Archive of Abstracts

2024   -   Prize Winners  |  All Abstracts
2023   -   Prize Winners  |  All Abstracts
2022   -   Prize Winners  |  All Abstracts
2021   -   Prize Winners  
2019   -   Podium  |  Poster
2018   -   Podium  |  Poster
2017   -   Podium  |  Poster
2016   -   Podium  |  Poster
2015   -   Podium  |  Poster
2014   -   Podium  |  Poster
2013   -   Podium  |  Poster
2011   -   All Abstracts
2009   -   All Abstracts
2008   -   All Abstracts
2007   -   All Abstracts
2006   -   All Abstracts
2005   -   All Abstracts
2004   -   All Abstracts
2002   -   All Abstracts
2001   -   All Abstracts
2000   -   All Abstracts
1999   -   All Abstracts
1998   -   All Abstracts
1997   -   All Abstracts
1996   -   All Abstracts
1995   -   All Abstracts
1994   -   All Abstracts
1993   -   All Abstracts
1991   -   All Abstracts
1990   -   All Abstracts
1989   -   All Abstracts
1987   -   All Abstracts
1985   -   All Abstracts
1983   -   All Abstracts